Converging evidence from clinical and experimental studies suggests a role for high serum calcium levels, particularly when associated with high phosphate levels, in the development and progression of vascular calcification. Changes in arterial structure as well as loss of compliance of arteries have been reported as early as in the second decade of life in children on dialysis [
5,
33‐
39], with approximately 20 % of children on dialysis shown to have coronary artery calcification on computed tomography (CT) scams, increased carotid intima-media thickness (cIMT) and calcified arteries [
5,
36,
39]. Evidence of vascular calcification on CT scans is directly related to a high serum calcium × phosphate (Ca–P) product, serum phosphate level, intake of calcium containing phosphate binders and plasma PTH levels [
34]. In a postmortem analysis of 120 children with CKD, soft tissue and vascular calcification was associated with the use of active vitamin D and calcium-containing phosphate binders [
40]. Progressive increase of cIMT has been associated with higher serum Ca–P product and PTH [
5,
41,
42]. In the seminal paper by Goodman et al., not only were the patients with coronary artery calcification older than those without calcification, but they also had a significantly higher mean serum Ca–P level (5.2 vs. 4.5 mmol
2/L
2) and almost double the intake of calcium from binders (6,456 vs. 3,325 mg/day) [
5]. The serum phosphate, Ca–P and PTH levels were very high in both patient groups, and the calcium intake from phosphate binders was significantly above the K/DOQI (National Kidney Foundation Kidney Disease Outcomes Quality Initiative) recommended limit of 1,500 mg/day, suggesting that these patients were at a substantial risk of ectopic calcification [
5]. Moreover, transient increases in calcium that occur in relation to dialysis [
43] and vitamin D or binder intake may go unrecorded, but these can impact on ectopic calcification, particularly in the setting of high phosphate conditions. In the ‘Treat-to-Goal’ study, the calcium-treated group had significantly more hypercalcaemic episodes than the sevelamer group [
8], and the extent of arterial calcification was directly related to the number of episodes of hypercalcaemia during the preceding 6 months [
8].
Studies on the role of calcium intake, from diet, binders or dialysate, on vascular calcification have not been performed in children. However, it is important to remember that the purpose of the calcium homeostatic system is to maintain the ECF calcium levels within a very tight range; consequently, serum calcium levels are a poor, and sometimes misleading, marker of total body calcium level. A recent study has shown that elevated serum calcium, phosphate and Ca–P product levels, but not dietary calcium or phosphate consumption, are associated with increased coronary artery calcification [
44].